TickerFacts.

Celldex Therapeutics, Inc. (CLDX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$3.38M
Year ended 2025-12-31
$3.40M
Trailing 12 months to 2026-06-30
+5.3%
3-year compound annual growth
-3.0%
5-year compound annual growth
+1.2%
10-year compound annual growth
$4.86M2009-12-31: $2.58M2010-12-31: $2.72M2011-12-31: $2.25M2012-12-31: $2.05M2013-12-31: $1.93M2014-12-31: $2.39M2015-12-31: $3.00M2016-12-31: $3.10M2017-12-31: $4.41M2018-12-31: $3.58M2019-12-31: $4.86M2020-12-31: $3.93M2021-12-31: $3.07M2022-12-31: $2.90M2023-12-31: $3.01M2024-12-31: $3.18M2025-12-31: $3.38M$3.38M
2009-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$3.38M+6.4%2026-02-25, From 2025-01-01
2024-12-31$3.18M+5.6%2026-02-25, From 2024-01-01
2023-12-31$3.01M+3.9%2026-02-25, From 2023-01-01
2022-12-31$2.90M-5.6%2025-02-27, From 2022-01-01
2021-12-31$3.07M-21.9%2024-02-26, From 2021-01-01
2020-12-31$3.93M-19.1%2023-02-28, From 2020-01-01
2019-12-31$4.86M+35.8%2022-02-28, From 2019-01-01
2018-12-31$3.58M-19.0%2021-03-29, From 2018-01-01
2017-12-31$4.41M+42.6%2020-03-26, From 2017-01-01
2016-12-31$3.10M+3.2%2019-03-07, From 2016-01-01
2015-12-31$3.00M+25.5%2018-03-07, From 2015-01-01
2014-12-31$2.39M+23.6%2017-03-14, From 2014-01-01
2013-12-31$1.93M-5.6%2016-02-25, From 2013-01-01
2012-12-31$2.05M-8.9%2015-02-24, From 2012-01-01
2011-12-31$2.25M-17.3%2014-03-03, From 2011-01-01
2010-12-31$2.72M+5.2%2013-03-08, From 2010-01-01
2009-12-31$2.58Mn/a2012-03-08, From 2009-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Celldex Therapeutics, Inc. (CLDX)2025-12-31$3.38M+6.4%
Volitionrx Ltd (VNRX)2025-12-31$983.7K-11.6%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$2.19M+48.4%
Biomerica Inc (BMRA)2026-05-31$77.0K-11.5%
Aspira Women's Health Inc. (AWHL)2025-12-31$112.0K+21.7%
Immucell Corp (ICCC)2025-12-31$2.78M+2.0%
Alpha Teknova, Inc. (TKNO)2025-12-31$6.34M-3.6%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$9.77M-5.0%
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31$65.2K+230.5%

Compare CLDX, VNRX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗